CA
SPPI

Commerzbank Aktiengesellschaft’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,293
Closed -$92K – 1203
2014
Q2 		$92K Buy
+11,293
New +$85.7K ﹤0.01% 1165

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Commerzbank Aktiengesellschaft's SPPI Position: Q3 2014 in Review

Commerzbank Aktiengesellschaft sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2014, closing a stake of 11,293 shares — an estimated $92K sold.

Commerzbank Aktiengesellschaft first reported a position in SPPI in Q2 2014 and held it in 1 quarter. The position peaked at $92K in Q2 2014. 127 funds tracked by Wall St. Rank hold SPPI as of Q3 2014.

  • Commerzbank Aktiengesellschaft reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 11,293 Spectrum Pharmaceuticals Inc shares in Q3 2014, an estimated $92K.
  • Commerzbank Aktiengesellschaft first reported a position in Spectrum Pharmaceuticals Inc in Q2 2014 and held it in 1 quarter.
  • Commerzbank Aktiengesellschaft's Spectrum Pharmaceuticals Inc position peaked at $92K in Q2 2014.
  • 127 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2014.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2014, filed 13 Nov 2014.